| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 5 | -1,642,876 | 100% | $1.57 | -$2,572,104 |
| Net | -5 | -1,642,876 | -100% | -$2,572,104 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| INTERWEST PARTNERS X LP | 10%+ Owner | $10,040,531 | 13 Jul 2021 | ||
| ORBIMED ADVISORS LLC | 10%+ Owner | $7,562,442 | -$2,420,000 | -24% | 23 Oct 2025 |
| Thilo Schroeder | Director | $2,455,861 | 06 Oct 2021 | ||
| David Henry Mack | President and CEO, Director | $697,788 | -$62,179 | -8.2% | 05 Mar 2026 |
| Euclidean Capital LLC | 10%+ Owner | $283,431 | 11 Jun 2021 | ||
| Robert Ticktin | General Counsel & COO | $105,090 | -$24,651 | -19% | 05 Mar 2026 |
| Leila Alland | Chief Medical Officer | $102,377 | 15 Sep 2023 | ||
| Deepika Jalota | Chief Development Officer | $95,761 | -$35,198 | -27% | 05 Mar 2026 |
| Michael Carulli | Chief Financial Officer | $92,310 | -$30,077 | -25% | 05 Mar 2026 |
| Winston Kung | Coo, Cfo | 12 May 2023 | |||
| Laurie Stelzer | Director | 05 Jun 2025 | |||
| Arnold J. Levine | Director | 05 Jun 2025 | |||
| Carol Giltner Gallagher | Director | 05 Jun 2025 | |||
| Richard A. Heyman | Director | 05 Jun 2025 | |||
| Charles M. Baum | Director | 05 Jun 2025 | |||
| Peter A. Thompson | Director, 10%+ Owner | 02 Jun 2021 | |||
| Kirsten Flowers | Director | 05 Jun 2025 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Michael Carulli | PMVP | Employee Stock Option (right to buy) | Award | 240,000 | 240,000 | 05 Mar 2026 | Direct | |||
| Robert Ticktin | PMVP | Employee Stock Option (right to buy) | Award | 319,270 | 319,270 | 05 Mar 2026 | Direct | |||
| Deepika Jalota | PMVP | Employee Stock Option (right to buy) | Award | 303,310 | 303,310 | 05 Mar 2026 | Direct | |||
| David Henry Mack | PMVP | Employee Stock Option (right to buy) | Award | 744,960 | 744,960 | 05 Mar 2026 | Direct | |||
| David Henry Mack | PMVP | Common Stock | Options Exercise | 95.7% | 220,643 | 451,109 | 27 Oct 2025 | Direct | ||
| David Henry Mack | PMVP | Employee Stock Option (right to buy) | Options Exercise | -100% | -220,643 | 0 | 27 Oct 2025 | Direct | ||
| Orbimed Advisors Llc | PMVP | Common Stock | Sale | -16.7% | $1,520,000 | $1.52 | -1,000,000 | 4,975,291 | 23 Oct 2025 | See Footnotes |
| Orbimed Advisors Llc | PMVP | Common Stock | Sale | -7.72% | $900,000 | $1.80 | -500,000 | 5,975,291 | 10 Sep 2025 | See Footnotes |
| Robert Ticktin | PMVP | Common Stock | Sale | -19% | $24,651 | $1.06 | -23,151 | 98,695 | 01 Jul 2025 | Direct |
| Deepika Jalota | PMVP | Common Stock | Sale | -26.9% | $35,198 | $1.06 | -33,065 | 89,959 | 01 Jul 2025 | Direct |
| Michael Carulli | PMVP | Common Stock | Sale | -32% | $30,077 | $1.06 | -28,249 | 60,146 | 01 Jul 2025 | Direct |
| David Henry Mack | PMVP | Common Stock | Sale | -9.82% | $62,179 | $1.06 | -58,411 | 536,133 | 01 Jul 2025 | Direct |
| Laurie Stelzer | PMVP | Stock Option (right to buy) | Award | 33,500 | 33,500 | 05 Jun 2025 | Direct | |||
| Arnold J. Levine | PMVP | Stock Option (right to buy) | Award | 33,500 | 33,500 | 05 Jun 2025 | Direct | |||
| Richard A. Heyman | PMVP | Stock Option (right to buy) | Award | 33,500 | 33,500 | 05 Jun 2025 | Direct | |||
| Carol Giltner Gallagher | PMVP | Stock Option (right to buy) | Gift | 33,500 | 33,500 | 05 Jun 2025 | See footnote | |||
| Carol Giltner Gallagher | PMVP | Stock Option (right to buy) | Gift | -100% | -33,500 | 0 | 05 Jun 2025 | Direct | ||
| Carol Giltner Gallagher | PMVP | Stock Option (right to buy) | Award | 33,500 | 33,500 | 05 Jun 2025 | Direct | |||
| Kirsten Flowers | PMVP | Stock Option (right to buy) | Award | 33,500 | 33,500 | 05 Jun 2025 | Direct | |||
| Charles M. Baum | PMVP | Stock Option (right to buy) | Award | 33,500 | 33,500 | 05 Jun 2025 | Direct |